18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma.

Power, Jack; Larcos, George

Power, Jack; Larcos, George.

Affiliation

Power J; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Larcos G; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

ANZ J Surg ; 93(1-2): 145-150, 2023 01.

Article in En | MEDLINE | ID: mdl-36582048

Subject(s)

Adenocarcinoma; Pancreatic Neoplasms; United States; Humans; Aged; Pancreatic Neoplasms/pathology; Fluorides; Fluorodeoxyglucose F18; Radiopharmaceuticals; Adenocarcinoma/surgery; Medicare; Positron-Emission Tomography/methods; Positron Emission Tomography Computed Tomography/methods; Neoplasm Staging; Retrospective Studies; Pancreatic Neoplasms

Key words

adenocarcinoma; pancreas; positron emission tomography; prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Country/Region as subject: America do norte Language: En Journal: ANZ J Surg Year: 2023 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google